Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients

Acta Neurologica Scandinavica

Volumn 115, Issue 1, 2007, Pages 67-72

  Tsivgoulis, G ^a,b   Triantafyllou, N ^a   Papageorgiou, C ^a   Evangelopoulos, M E ^a   Kararizou, E ^a   Sfagos, C ^a   Vassilopoulos, D ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Anxiety; Depression; Disability; Multiple sclerosis

Indexed keywords

BETA INTERFERON; GLATIRAMER;

ADULT; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTPATIENT; PATIENT EDUCATION; STATE TRAIT ANXIETY INVENTORY;

ADULT; ANXIETY DISORDERS; BIOLOGICAL RESPONSE MODIFIERS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DISABILITY EVALUATION; EDUCATIONAL STATUS; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS;

EID: 33845487912     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00736.x     Document Type: Article

References (26)

1. SADOVNICK AD, REMICK RA, ALLEN J et al. Depression and multiple sclerosis. Neurology 1996;46:628-32.
2. MINDEN SL. Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol 2000;6:S160-7.
3. LYNCH SG, KROENCKE DC, DENNEY DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler 2001;7:411-6.
4. LOBENTANZ IS, ASENBAUM S, VASS K et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004;110:6-13.
5. ZORZON M, DE MASI R, NASUELLI D et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 2001;248:416-21.
6. ZEPHIR H, DE SEZE J, STOJKOVIC T et al. Multiple sclerosis and depression: influence of interferon beta therapy. Mult Scler 2003;9:284-8.
7. MOLLER A, WIEDEMANN G, ROHDE U, BACKMUND H, SONNTAG A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 1994;89:117-21.
8. GALEAZZI GM, FERRARI S, GIAROLI G et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005;26:255-62.
9. CHWASTIAK L, EHDE DM, GIBBONS LE, SULLIVAN M, BOWEN JD, KRAFT GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002;159:1862-8.
10. PATTEN SB, METZ LM, REIMER MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 2000;6:115-20.
11. JACOBS LD, BECK RW, SIMON JH et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000;343:898-904.
12. JANSSENS AC, VAN DOORN PA, DE BOER JB et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003;9:397-403.
13. DI LEGGE S, PIATTELLA MC, POZZILLI C et al. Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis. Mult Scler 2003;9:302-6.
14. MCDONALD WI, COMPSTON A, EDAN G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
15. TRIANTAFYLLOU NI, VOUMVOURAKIS K, ZALONIS I et al. Cognition in relapsing-remitting multiple sclerosis: a multichannel event-related potential (P300) study. Acta Neurol Scand 1992;85:10-3.
16. KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
17. SFAGOS C, PAPAGEORGIOU CC, KOSMA KK et al. Working memory deficits in multiple sclerosis: a controlled study with auditory P600 correlates. J Neurol Neurosurg Psychiatry 2003;74:1231-5.
18. BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
19. FOUNTOULAKIS KN, PAPADOPOULOU M, KLEANTHOUS S et al. Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory form Y: preliminary data. Ann Gen Psychiatry 2006;5:2.
20. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
21. PUJOL J, BELLO J, DEUS J, CARDONER N, MARTI-VILALTA JL, CAPDEVILA A. Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region. Psychiatry Res 2000;99:151-9.
22. BERG D, SUPPRIAN T, THOMAE J et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 2000;6:156-62.
23. EATON WW, KRAMER M, ANTHONY JC, DRYMAN A, SHAPIRO S, LOCKE BZ. The incidence of specific DIS/DSM-III mental disorders: data from the NIHM Epidemiologic Catchment Area Program. Acta Psychiatr Scand 1989;79:163-78.
24. SOLARI A, AMATO MP, BERGAMASCHI R et al. Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. Acta Neurol Scand 1993;87:43-6.
25. HUIJBREGTS SC, KALKERS NF, DE SONNEVILLE LM, DE GROOT V, REULING IE, POLMAN CH. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004;63:335-9.
26. FRUEHWALD S, LOEER-STASTKA H, EHER R, SALETU B, BAUMHACKL U. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001;104:257-61.